Alfred D. Kingsley is also Chairman of the Board of BioTime, Inc. Mr. Kingsley has been general partner of Greenway Partners, L.P., a private investment firm, and President of Greenbelt Corp., a business consulting firm, since 1993. Mr. Kingsley was Senior Vice President of Icahn and Company and its affiliated entities for more than 25 years.
Mr. Kingsley holds a BS degree in economics from the Wharton School of the University of Pennsylvania, and a J.D. degree and LLM in taxation from New York University Law School.
Mr. Guan-Golan is the CEO of LifeMap Sciences and was a founding member of the company, as well as member of the founding team of Xennex, Inc, which was acquired by LifeMap Sciences. He was CEO and senior executive at three startup companies in Hong Kong, Israel and Boston, after completing 5 years of service in the Israeli Defense Forces.
Yaron holds an MBA from the Hong Kong University of Science and Technology and a Bachelors of Sciences from the Open University of Israel.
Michael H. Mulroy joined LifeMap Sciences’ board of directors in November 2015. He is also a member of the BioTime Board of Directors. Mr. Mulroy is a business consultant and serves as the President of Mulroy Advisors, LLC. Mr. Mulroy served until September 2014 as Executive Vice President – Strategic Affairs and General Counsel of the Autoimmune and Rare Diseases Business Unit of Mallinckrodt plc following its acquisition of Questcor Pharmaceuticals, Inc. in August 2014. Mr. Mulroy was appointed Executive Vice President, Strategic Affairs and General Counsel and Corporate Secretary of Questcor in February 2014, having previously served as Chief Financial Officer, General Counsel and Corporate Secretary since January 2011. From 2003 to 2011, Mr. Mulroy was employed by the law firm of Stradling Yocca Carlson & Rauth, where he served as a partner from 2004, and represented Questcor and other publicly-traded companies. From 1997 to 2003, Mr. Mulroy was an investment banker at Citigroup and Merrill Lynch. From July 2011 to August 2014, Mr. Mulroy served as a member of the Board of Directors of Comarco, Inc., which developed and designed innovative technologies and intellectual property used in power adapters. Mr. Mulroy earned his J.D. degree from the University of California, Los Angeles and his B.A. (Economics) from the University of Chicago.
Mr. Mulroy brings to our Board his experience as a strategic planner and as legal counsel and member of a senior management team of a growing biopharmaceutical company. Mr. Mulroy also brings to our Board his experience in corporate finance and investor relations.
Mr. Silverman joined LifeMap Sciences’ board of directors in October 2012. Mr. Silverman is an experienced healthcare executive with board level and operating experience in healthcare IT, pharmaceuticals, home health care, worker’s compensation managed care and revenue cycle management. Currently, Mr. Silverman is Chairman and CEO of Advanced ICU Care, the largest independent provider of telemedicine solutions to hospital intensive care units in the US. From September 2009 through to its successful sale in June of 2012, Mr. Silverman was the Chief Executive Officer of privately held Marina Medical Billing Service Inc., a company focused on providing revenue cycle management services nationally to emergency room physicians. Prior to joining Marina Medical, Mr. Silverman was President and Chief Executive Officer of Lifecomm, Inc., a Qualcomm Incorporated incubated wireless health services start-up. From 2000 – 2008, Mr. Silverman was President and Chief Executive Officer of Quality Systems, Inc., a developer of medical and dental practice management software, which he led to significant revenue growth and an increase in market value from $42 million to $1.2 billion. Previously, Mr. Silverman was the Chief Operations Officer of Corvel Corporation. Mr. Silverman currently serves as a member of the Board of Directors of STAAR Surgical (NASDAQ: STAA) and also serves as Chairman of the Board of Comarco, Inc.(OTC :CMRO.PK).
Mr. Silverman earned a Bachelor of Arts degree from Amherst College and a Masters in Business Administration from Harvard Graduate School of Business Administration.
Michael D. West, Ph.D., is the key driving force behind the concept of the LifeMap Discovery database. He is a pioneer in the field of stem cell research and has extensive academic and business experience in age-related degenerative diseases, telomerase molecular biology and human embryonic stem cell research and development. Dr. West is the CEO of BioTime, Inc. and has served on the BioTime Board of Directors since 2002. Prior to joining BioTime, Dr. West served as President and Chief Scientific Officer of Advanced Cell Technology, Inc., a company engaged in developing human stem cell technology for use in regenerative medicine. Dr. West also founded Geron Corporation where he initiated and managed programs in telomerase diagnostics, oligonucleotide-based telomerase inhibition as anti-tumor therapy, and the cloning and use of telomerase in telomerase-mediated therapy wherein telomerase is utilized to immortalize human cells, and he initiated and managed the original collaborative effort that led to the first isolation of human embryonic stem and embryonic germ cells. Dr. West is an inventor named on over 60 patents and patent applications in the field of biotech and also serves as an Adjunct Professor of Bioengineering at the University of California, Berkeley.
Dr. West received a B.S. Degree from Rensselaer Polytechnic Institute in 1976, an M.S. Degree in Biology from Andrews University in 1982, and a Ph.D. from Baylor College of Medicine in 1989 conentrating on the biology of cellular aging. Dr. West's complete CV and background on his research interests are available online at: www.michaelwest.org.